Logs: Bang Zheng
The following is a list of all job requests run via OpenSAFELY by Bang Zheng.
| Status | Organisation | Project | Workspace | Request ID | Backend | Jobs | Started | View request |
|---|---|---|---|---|---|---|---|---|
| Succeeded | Bennett Institute | Coverage, effectiveness and safety of neutralising monoclonal antibodies or antivirals for non-hospitalised patients with COVID-19 | paxlovid_sotrovimab | 12728 | TPP | 1/1 | 3 years, 1 month ago 27 October 2022 08:34:39 UTC | View, Job request 12728 |
| Succeeded | Bennett Institute | Coverage, effectiveness and safety of neutralising monoclonal antibodies or antivirals for non-hospitalised patients with COVID-19 | paxlovid_sotrovimab | 12726 | TPP | 1/1 | 3 years, 1 month ago 27 October 2022 08:04:03 UTC | View, Job request 12726 |
| Succeeded | Bennett Institute | Coverage, effectiveness and safety of neutralising monoclonal antibodies or antivirals for non-hospitalised patients with COVID-19 | paxlovid_sotrovimab | 12725 | TPP | 1/1 | 3 years, 1 month ago 27 October 2022 07:57:57 UTC | View, Job request 12725 |
| Succeeded | Bennett Institute | Coverage, effectiveness and safety of neutralising monoclonal antibodies or antivirals for non-hospitalised patients with COVID-19 | paxlovid_sotrovimab | 12724 | TPP | 2/2 | 3 years, 1 month ago 27 October 2022 07:35:11 UTC | View, Job request 12724 |
| Succeeded | Bennett Institute | Coverage, effectiveness and safety of neutralising monoclonal antibodies or antivirals for non-hospitalised patients with COVID-19 | paxlovid_sotrovimab | 12723 | TPP | 1/1 | 3 years, 1 month ago 27 October 2022 07:07:41 UTC | View, Job request 12723 |
| Failed | Bennett Institute | Coverage, effectiveness and safety of neutralising monoclonal antibodies or antivirals for non-hospitalised patients with COVID-19 | paxlovid_sotrovimab | 12722 | TPP | 0/1 | 3 years, 1 month ago 27 October 2022 06:49:46 UTC | View, Job request 12722 |
| Failed | Bennett Institute | Coverage, effectiveness and safety of neutralising monoclonal antibodies or antivirals for non-hospitalised patients with COVID-19 | paxlovid_sotrovimab | 12721 | TPP | 1/2 | 3 years, 1 month ago 27 October 2022 06:10:30 UTC | View, Job request 12721 |
| Failed | Bennett Institute | Coverage, effectiveness and safety of neutralising monoclonal antibodies or antivirals for non-hospitalised patients with COVID-19 | paxlovid_sotrovimab | 12720 | TPP | 1/2 | 3 years, 1 month ago 26 October 2022 22:30:17 UTC | View, Job request 12720 |
| Succeeded | Bennett Institute | Coverage, effectiveness and safety of neutralising monoclonal antibodies or antivirals for non-hospitalised patients with COVID-19 | paxlovid_sotrovimab | 12719 | TPP | 2/2 | 3 years, 1 month ago 26 October 2022 21:55:03 UTC | View, Job request 12719 |
| Succeeded | Bennett Institute | Coverage, effectiveness and safety of neutralising monoclonal antibodies or antivirals for non-hospitalised patients with COVID-19 | paxlovid_sotrovimab | 12708 | TPP | 2/2 | 3 years, 1 month ago 26 October 2022 15:23:22 UTC | View, Job request 12708 |
| Failed | Bennett Institute | Coverage, effectiveness and safety of neutralising monoclonal antibodies or antivirals for non-hospitalised patients with COVID-19 | paxlovid_sotrovimab | 12694 | TPP | 1/2 | 3 years, 1 month ago 26 October 2022 10:41:04 UTC | View, Job request 12694 |
| Failed | Bennett Institute | Coverage, effectiveness and safety of neutralising monoclonal antibodies or antivirals for non-hospitalised patients with COVID-19 | paxlovid_sotrovimab | 12692 | TPP | 0/1 | 3 years, 1 month ago 26 October 2022 10:05:09 UTC | View, Job request 12692 |
| Succeeded | Bennett Institute | Coverage, effectiveness and safety of neutralising monoclonal antibodies or antivirals for non-hospitalised patients with COVID-19 | paxlovid_sotrovimab | 12691 | TPP | 1/1 | 3 years, 1 month ago 26 October 2022 09:59:54 UTC | View, Job request 12691 |
| Failed | Bennett Institute | Coverage, effectiveness and safety of neutralising monoclonal antibodies or antivirals for non-hospitalised patients with COVID-19 | paxlovid_sotrovimab | 12685 | TPP | 0/1 | 3 years, 1 month ago 25 October 2022 22:12:15 UTC | View, Job request 12685 |
| Succeeded | Bennett Institute | Coverage, effectiveness and safety of neutralising monoclonal antibodies or antivirals for non-hospitalised patients with COVID-19 | paxlovid_sotrovimab | 12683 | TPP | 1/1 | 3 years, 1 month ago 25 October 2022 21:55:05 UTC | View, Job request 12683 |
| Failed | Bennett Institute | Coverage, effectiveness and safety of neutralising monoclonal antibodies or antivirals for non-hospitalised patients with COVID-19 | paxlovid_sotrovimab | 12682 | TPP | 0/1 | 3 years, 1 month ago 25 October 2022 21:47:13 UTC | View, Job request 12682 |
| Failed | Bennett Institute | Coverage, effectiveness and safety of neutralising monoclonal antibodies or antivirals for non-hospitalised patients with COVID-19 | paxlovid_sotrovimab | 12681 | TPP | 0/1 | 3 years, 1 month ago 25 October 2022 21:31:18 UTC | View, Job request 12681 |
| Failed | Bennett Institute | Coverage, effectiveness and safety of neutralising monoclonal antibodies or antivirals for non-hospitalised patients with COVID-19 | paxlovid_sotrovimab | 12680 | TPP | 0/1 | 3 years, 1 month ago 25 October 2022 21:17:19 UTC | View, Job request 12680 |
| Succeeded | The London School of Hygiene & Tropical Medicine | Effectiveness safety sotrovimab molnupiravir | sotrovimab_molnupiravir | 12678 | TPP | 1/1 | 3 years, 1 month ago 25 October 2022 20:57:29 UTC | View, Job request 12678 |
| Failed | Bennett Institute | Coverage, effectiveness and safety of neutralising monoclonal antibodies or antivirals for non-hospitalised patients with COVID-19 | paxlovid_sotrovimab | 12677 | TPP | 1/2 | 3 years, 1 month ago 25 October 2022 18:12:01 UTC | View, Job request 12677 |
| Succeeded | Bennett Institute | Coverage, effectiveness and safety of neutralising monoclonal antibodies or antivirals for non-hospitalised patients with COVID-19 | paxlovid_sotrovimab | 12673 | TPP | 2/2 | 3 years, 1 month ago 25 October 2022 17:17:50 UTC | View, Job request 12673 |
| Failed | Bennett Institute | Coverage, effectiveness and safety of neutralising monoclonal antibodies or antivirals for non-hospitalised patients with COVID-19 | paxlovid_sotrovimab | 12672 | TPP | 0/2 | 3 years, 1 month ago 25 October 2022 16:57:47 UTC | View, Job request 12672 |
| Succeeded | Bennett Institute | Coverage, effectiveness and safety of neutralising monoclonal antibodies or antivirals for non-hospitalised patients with COVID-19 | paxlovid_sotrovimab | 12671 | TPP | 1/1 | 3 years, 1 month ago 25 October 2022 15:41:03 UTC | View, Job request 12671 |
| Succeeded | Bennett Institute | Coverage, effectiveness and safety of neutralising monoclonal antibodies or antivirals for non-hospitalised patients with COVID-19 | paxlovid_sotrovimab | 12668 | TPP | 1/1 | 3 years, 1 month ago 25 October 2022 15:22:01 UTC | View, Job request 12668 |
| Failed | Bennett Institute | Coverage, effectiveness and safety of neutralising monoclonal antibodies or antivirals for non-hospitalised patients with COVID-19 | paxlovid_sotrovimab | 12666 | TPP | 0/1 | 3 years, 1 month ago 25 October 2022 15:05:09 UTC | View, Job request 12666 |